GO
Loading...

Cancer Drug Gets Green Light

Friday, 15 Jul 2011 | 6:45 AM ET

An FDA panel votes 10-0 for approval of a drug to treat Hodgkin's disease. Insight with Clay Siegall, Seattle Genetics president/CEO.